Clinical evaluation of combined therapy for type 2 diabetes

Author： Rodríguez Ángel   Ciprés Luis   Tofé Santiago   Polavieja Pepa   Reviriego Jesús  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.26, Iss.5, 2010-05, pp. : 1171-1183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prescribing practices and clinical predictors of glucose‐lowering therapy within the first year in people with newly diagnosed Type 2 diabetes

By  

DIABETIC MEDICINE, Vol. 32, Iss. 12, 2015-12 ,pp. : 1546-1554

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lipid lowering therapy in type 2 diabetes

By Föger Bernhard  

Wiener Medizinische Wochenschrift, Vol. 161, Iss. 11-12, 2011-06 ,pp. : 289-296

Springer Publishing Company

Access to resources Recommend Favorite

Xultophy: combination therapy for the treatment of type 2 diabetes

By  

PRESCRIBER, Vol. 26, Iss. 17, 2015-09 ,pp. : 32-34

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of therapy with metformin plus pioglitazone in the treatment of patients with type 2 diabetes: a double-blind, placebo-controlled, clinical trial

By Kaku Kohei  

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1111-1119

Informa Healthcare

Access to resources Recommend Favorite

Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial

By Umpierrez Guillermo   Issa Maher   Vlajnic Aleksandra  

Current Medical Research and Opinion, Vol. 22, Iss. 4, 2006-04 ,pp. : 751-759

Informa Healthcare

Access to resources Recommend Favorite